Private Label Brightening Body Milk Low MOQ Supplier

For a stock or white-label formula that already contains tranexamic acid and kojic acid, most contract manufacturers can work at MOQs between 200 and 500 units. These are pre-validated bases where the manufacturer has already done stability and preservation testing, so the risk is lower and they can afford smaller runs. Semi-custom work — adjusting actives, fragrance, or packaging format — generally requires 500 to 1,500 units to cover the additional development and QC cost. Fully custom formulations with bespoke active concentrations, a proprietary emulsion structure, and full formula IP ownership typically start at 1,500 units and more commonly 3,000 to 5,000 for the economics to work for the manufacturer. Several factors push MOQs up or down. Fill size matters: a 16 oz pump bottle requires more fill volume per unit than a 6 oz tube, which raises batch minimums. Packaging sourcing is another lever — if you choose a stock bottle the manufacturer already warehouses, you avoid tooling fees and the MOQ can stay lower. Custom bottles or airless dispensers often have their own packaging MOQs of 2,000 to 5,000 pieces, which effectively sets your floor. Your geography matters too: US-based manufacturers tend to accept lower MOQs than Asian contract manufacturers, who often start at 1,000 to 3,000 units but offer lower per-unit COGS. Kojic acid specifically creates a stability challenge that not all low-MOQ manufacturers handle well. It oxidises in the presence of light and at elevated pH, turning the product yellow or brown — a major quality failure. Manufacturers who specialise in brightening actives typically run smaller batch sizes more carefully than generalist body care co-packers. When you vet partners, ask specifically what their kojic acid stabilisation protocol is and request photos or video of finished product colour from a previous batch. The common mistake first-timers make is choosing a manufacturer purely on price and MOQ without requesting stability data. A 200-unit MOQ at $5 per unit looks attractive until the product arrives discoloured and unsellable, or fails a 3-month consumer-use test. Always request at least 12-week accelerated stability data (40°C/75% RH) before committing to a production run, regardless of MOQ. AJ Cosmo Labs surfaces manufacturers filtered by MOQ, so you can immediately see who can serve a 200-unit starter run versus who requires 2,000+ units. Download the iOS app and post your brief with your target MOQ — matched manufacturers will respond with quotes directly.

Cost of goods sold (COGS) for a private label brightening body milk sits in a wide range depending on formula complexity, active concentrations, fill size, and packaging. For a stock formula in a standard pump or flip-cap bottle at 200 to 500 units, expect to pay $4 to $9 per finished unit. Semi-custom work with adjusted TXA and kojic acid concentrations and branded packaging typically lands between $7 and $14 per unit at 500 to 1,500 units. Fully custom formulas with clinical-grade active loads and premium packaging can reach $15 to $25 or more per unit at lower volumes. Beyond per-unit COGS, budget for these line items that first-timers often miss. Formula development fees range from $500 to $3,500 for semi-custom work and $2,000 to $8,000 for fully bespoke development — some manufacturers waive this once you hit a production threshold. Stability testing adds $400 to $1,500 depending on scope (accelerated vs real-time). A challenge test (preservation efficacy testing) costs $300 to $800. An EU Cosmetic Product Safety Report, if you plan European distribution, costs $600 to $2,000 per formula. Artwork and label printing for 500 to 1,000 labels runs $150 to $500. Freight from manufacturer to your warehouse varies by weight and origin country but budget 8 to 15% of order value for domestic US and 12 to 22% for overseas shipments. Raw material costs for the actives themselves are worth understanding. Pharmaceutical-grade tranexamic acid runs approximately $30 to $80 per kilogram at small volumes. Kojic acid runs $20 to $60 per kilogram. These are minor inputs in the overall formulation cost at typical use levels (1–3% TXA, 0.5–2% kojic acid), but if your manufacturer is quoting unusually cheap COGS, verify you're getting the correct active concentrations — diluting the actives is the easiest way to hit a low price point. Retail pricing for a brightening body milk with these actives generally ranges from $18 to $55 at mass-premium to prestige positioning. To maintain a healthy 4x to 6x markup on COGS, you need your landed unit cost (COGS + freight + duties) to sit at 16 to 25% of your retail price. If the math doesn't work at low MOQ, consider launching with a stock formula at lower MOQ to build cash flow before investing in a custom formulation. AJ Cosmo Labs lets you receive competitive quotes from multiple vetted manufacturers in the same brief cycle, so you can compare total cost — not just per-unit COGS — before committing.

The total timeline from initial brief to finished goods in your warehouse depends on which development path you choose. For a stock or white-label formula, the timeline is shortest: 4 to 8 weeks, primarily consumed by label design, printing, and filling. The formula is already validated, so you skip the development and stability phases. For semi-custom work, the timeline breaks down roughly like this. Manufacturer briefing and formula selection takes 1 to 2 weeks. Sample production and internal review by the manufacturer takes 1 to 3 weeks. You receive samples, review, and provide feedback — this takes 1 to 2 weeks on your side. A second sample round, if needed (which it usually is for active-heavy formulas like TXA + kojic acid combinations), adds another 2 to 4 weeks. Once the formula is approved, stability testing should run a minimum of 8 to 12 weeks at accelerated conditions before you proceed to bulk production, though some founders accept shorter stability windows and accept the risk. Bulk production itself takes 2 to 6 weeks depending on batch size, fill speed, and the manufacturer's queue. Label printing and assembly takes 1 to 3 weeks. Freight from a US manufacturer is 1 to 5 days; from an overseas manufacturer, 3 to 6 weeks by sea or 1 to 2 weeks by air. Total semi-custom timeline: 14 to 22 weeks under normal conditions. Fully custom development adds more iteration rounds. Expect 5 to 9 months from brief to finished goods if you include proper stability testing and a challenge test. This is the correct timeline — anyone promising a custom brightening body milk in 6 weeks is either skipping stability or handing you someone else's formula with your label. Kojic acid stability is the variable most likely to add time to your project. If your first sample rounds show oxidation (yellowing), the manufacturer needs to reformulate antioxidant support or adjust pH buffering, which adds 2 to 4 weeks per iteration. Budget for this proactively. The most common timeline mistake is placing your first production order before stability data is complete. Brands that rush into retail with an unstable formula face batch recalls, customer complaints, and supplier disputes that cost far more time and money than the extra weeks of testing would have. Use the time wisely: build your marketing assets, file any necessary regulatory notifications, and finalise retail agreements while the manufacturer finalises your formula. AJ Cosmo Labs helps you manage the development timeline inside the app, with sample tracking and milestone notifications so you always know what stage your project is at.

Tranexamic acid (TXA) is a synthetic amino acid derivative with a well-documented safety profile in pharmaceutical applications. At topical cosmetic concentrations — typically 1 to 3% — it is considered safe for use in leave-on skin care, including body milks, based on published clinical data and dermatologist review. The FDA does not currently restrict TXA as a cosmetic ingredient in the United States, and it appears in numerous commercially available brightening products across mass, masstige, and prestige channels without restriction. The critical regulatory issue in the US is not the ingredient itself but the claims you make on the label and in marketing. If you describe the product as treating melasma, reversing hyperpigmentation, or otherwise altering skin biology in a way that implies drug action, the FDA can classify your product as an OTC drug. Drug products require either a New Drug Application or compliance with a monograph — neither of which TXA currently has an established path for in the US OTC drug context. Stick to cosmetic structure-function language: 'visibly brightens', 'promotes an even-looking complexion', 'skin appears more luminous'. Have these claims reviewed by a regulatory affairs consultant before you go to print. In the European Union, tranexamic acid is not currently listed as a restricted or prohibited ingredient in the Cosmetics Regulation (EC) No 1223/2009. However, the EU requires a Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor before any product can be placed on the EU market. This CPSR must assess TXA at your specific use concentration. Your manufacturer can sometimes arrange CPSR services, or you can engage an independent EU regulatory consultant — costs typically run €600 to €1,800 per formula. Kojic acid has a more complex EU history. The EU Scientific Committee on Consumer Safety (SCCS) has issued opinions on kojic acid at various concentrations, and it has faced temporary restrictions in face products above 1%. At the time of writing, kojic acid is permitted in face products up to 1% and in body products up to certain concentrations, but regulations do change — always verify current Annex II, III, and V listings with an EU-qualified regulatory consultant before finalising your formula for European distribution. For the UK post-Brexit, the Great Britain cosmetics regulation broadly mirrors the EU framework but is administered by the OPSS under UK REACH and the Cosmetic Products (Safety) Regulations 2004 as amended. Notify via the UK Cosmetic Product Notification Portal (CPNP equivalent) before placing product on the GB market. In markets like South Korea, Japan, and several Southeast Asian countries, both TXA and kojic acid are widely used and often more permissively regulated, with established safety dossiers. If you're targeting these markets, work with a local regulatory agent to navigate MFDS (Korea), PMDA (Japan), or ASEAN Cosmetic Directive requirements. Always instruct your cosmetic chemist or the manufacturer's in-house formulator to provide a full safety justification document alongside the INCI list. AJ Cosmo Labs manufacturers listed on the platform are asked to confirm GMP compliance and safety assessment practices as part of the onboarding process.

Choosing the wrong manufacturer for an active-heavy formula like a kojic acid and tranexamic acid body milk is one of the most expensive mistakes in indie beauty. The right vetting process covers five areas: manufacturing credentials, active ingredient expertise, quality documentation, IP protection, and commercial terms. On manufacturing credentials, prioritise facilities operating under ISO 22716 (Good Manufacturing Practices for Cosmetics) or equivalent GMP certification. This is not just a quality signal — it is increasingly required by retailers and is mandatory for EU market access. Ask for their certificate and verify the issuing body. A US manufacturer operating under FDA Voluntary Cosmetic Registration Programme (VCRP) status is a positive indicator for US-market brands. On active ingredient expertise, ask these specific questions before sharing your formula brief: Have you manufactured products containing kojic acid before? How do you control for kojic acid oxidation during production? What pH range do you target for active-brightening emulsions? What chelating agents do you use, and why? A manufacturer who can answer these fluently has real experience. One who pivots to generic quality-language without specifics has probably not made this SKU before. On quality documentation, you should receive, at minimum: a Certificate of Analysis (COA) for each batch; an INCI ingredient list; a Safety Data Sheet for kojic acid and TXA raws; pH and viscosity specs with tolerances; a preservation efficacy (challenge) test result; and at least 8 weeks of accelerated stability data (12 weeks preferred). If a manufacturer says stability testing is 'optional', walk away. On IP protection, clarify formula ownership before development starts. With a stock formula, you typically do not own the IP — the manufacturer retains the right to sell the same base to other brands. With fully custom development, negotiate a formula assignment or exclusivity clause. Get this in writing, reviewed by a lawyer familiar with manufacturing agreements. Also confirm NDA terms are in place before sharing any existing formula you've developed independently. On commercial terms, evaluate: total development cost (not just per-unit price), payment milestones and escrow options, sample fee policy, revision limits, minimum reorder quantities, lead times for reorders after the first production run, and quality dispute resolution procedures. A manufacturer who requires 100% upfront payment with no milestone structure is a higher-risk partner than one who accepts staged payments tied to deliverables. The most common mistake first-timers make is over-weighting price in the selection decision. A manufacturer who quotes $3.50 per unit when comparable bids are $6 to $7 is almost certainly cutting corners — on active concentrations, on stability testing, on packaging quality, or on GMP compliance. The cheapest bid is rarely the lowest total cost of launch. AJ Cosmo Labs pre-screens manufacturers on its platform for GMP compliance and industry experience, reducing the vetting burden for founders. Open the iOS app, post your brief, and let matched suppliers come to you — then use the in-app messaging thread to ask the vetting questions above before signing anything.

Kojic acid and tranexamic acid brighten skin through entirely different biochemical pathways, which is exactly why combining them in one formula tends to produce stronger visible results than either ingredient used alone. Understanding the mechanism helps you formulate more intelligently and make more credible, defensible claims. Kojic acid (5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one) works by chelating copper ions. Tyrosinase, the key enzyme in the melanin biosynthesis pathway, requires a copper cofactor to function. By binding that copper, kojic acid inhibits tyrosinase activity and reduces the conversion of tyrosine to DOPA and eventually to melanin. It is a direct enzymatic inhibitor. At use levels of 0.5 to 2% in a leave-on body product, kojic acid produces measurable brightening effects with a favourable safety profile, though some individuals report mild irritation or contact dermatitis at higher concentrations. Transexamic acid (4-(aminomethyl)cyclohexanecarboxylic acid, sometimes written as tranexamic acid or TXA) works upstream of tyrosinase. It inhibits the interaction between keratinocytes and melanocytes by blocking plasminogen activator-plasmin signalling. UV radiation activates plasmin, which in turn stimulates melanocytes to produce more melanin. By interrupting this cascade, TXA reduces UV-induced pigmentation without directly touching tyrosinase. This makes it a mechanistically complementary partner to kojic acid — they target two different points in the same overall pathway. The two can absolutely be combined, and many leading brightening body milks on the market already use this pairing. The key formulation challenge is pH compatibility. Kojic acid is most stable and most effective in a slightly acidic environment, ideally pH 4.5 to 5.5. TXA is more pH-tolerant. Keeping the emulsion in that acidic range requires appropriate buffering and is achievable in an oil-in-water body milk base. Antioxidants such as ascorbic acid, sodium ascorbyl phosphate, or ferulic acid should be included to protect against kojic acid oxidation, which turns the product yellow-brown and signals degradation. Other actives that pair well in this type of formula include niacinamide (another melanin-transfer inhibitor, though watch for flushing reactions if combined with ascorbic acid at high concentrations), alpha arbutin, and azelaic acid. Avoid combining kojic acid with highly alkaline ingredients or with heavy metal ion sources (some pigments) that could outcompete kojic acid's chelating activity. For body application, both ingredients are safe in leave-on formulas at typical concentrations. Rinse-off use is less effective for actives that work by accumulation. A body milk format — lightweight, fast-absorbing — is well-suited for daily full-body use, which is how you build the consistent exposure needed for visible results over a 4 to 12 week period. When you post your brief on AJ Cosmo Labs, include your target actives and concentrations explicitly so manufacturers can confirm their experience with this pairing before you invest time in a sample round.

Finding a verified, low-MOQ contract manufacturer for a product as specific as a tranexamic acid and kojic acid brightening body milk requires more than a Google search or a cold email to a trade directory. The challenge is specificity: most broad directories list thousands of manufacturers without filtering for GMP certification, active ingredient experience, or minimum order quantity. You end up spending weeks on outreach, sending RFQs into the void, and waiting for responses that either don't come or come from manufacturers who've never worked with brightening actives. The most reliable sourcing approaches combine structured marketplace tools with targeted vetting. Start by defining your brief precisely before you contact anyone: target active concentrations (e.g. 2% TXA, 1% kojic acid), target pH range, viscosity and texture profile, fill size (e.g. 8 oz pump bottle), packaging format, target MOQ, budget per unit, and target market (US, EU, or both — because regulatory requirements differ). A vague brief produces vague responses from manufacturers who are guessing at your needs. Trade shows like Cosmoprof North America, In-Cosmetics Global, and Suppliers Day (ICMAD) are high-value in-person sourcing venues where you can meet contract manufacturers face to face, verify their sample quality on the spot, and begin relationship-building. However, they're time-intensive and occur once or twice a year — not useful if you need to move faster. Online B2B marketplaces purpose-built for cosmetics are faster. AJ Cosmo Labs is one of the most direct-action options: you post a detailed brief through the iOS app, and vetted manufacturers who work in your MOQ range and have brightening active experience respond directly. The app allows you to message them, track sample rounds, and manage milestone-based payments in escrow — all without leaving one platform. It removes the coordination overhead that kills early-stage brand timelines. When evaluating any manufacturer who responds, apply the vetting framework: request GMP certification, ask for previous kojic acid stability data, confirm they can produce a CPSR-ready formula if you need EU access, and review their quality dispute resolution terms before signing. Ask for two to three references from brands currently selling products the manufacturer made for them — and actually call those references. For a low-MOQ starting run of 200 to 500 units, domestic US manufacturers are usually more accessible and offer faster turnaround than overseas alternatives. For runs above 1,500 units where cost-efficiency becomes critical, Asian manufacturers — particularly in South Korea, which has deep regulatory and formulation expertise in brightening actives — often provide better value. South Korean OEM/ODM partners frequently work with TXA and kojic acid combinations because the K-beauty market has high domestic demand for brightening body care. Download AJ Cosmo Labs from the App Store and post your brief today. Include your active targets, your MOQ floor, and your target market, and you'll receive matched manufacturer responses typically within 24 to 48 hours — cutting weeks off the sourcing process.